Soteropoulos Paula
SEC Form 4 insider trading activity
Soteropoulos Paula has filed 4 SEC Form 4 filings (7 transaction rows) across 2 companies, including RLYB, DNTH, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Oct 20, 2026.
On the most recent filing, Soteropoulos Paula is listed as Director at Dianthus Therapeutics, Inc. Inside the rolling window, Soteropoulos Paula reported no open-market purchases and 3 open-market sales totaling $2.3M in DNTH. The largest disclosed transaction in the window is a sale of 27,594 DNTH shares on Mar 24, 2026, worth $2.2M.
Companies traded
Other insiders at RLYB
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.3M
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Soteropoulos Paula made?
Soteropoulos Paula has filed 4 SEC Form 4 filings (7 transaction rows) across 2 companies, including RLYB, DNTH since 2026.
Which companies does Soteropoulos Paula trade?
Soteropoulos Paula has filed SEC Form 4 disclosures for 2 companies, including RLYB, DNTH.
When was Soteropoulos Paula's most recent SEC Form 4 filing?
Soteropoulos Paula's most recent SEC Form 4 filing on Tracefour is dated Oct 20, 2026.
What is Soteropoulos Paula's total buy and sell value in the current window?
Inside the rolling retention window, Soteropoulos Paula bought $0 and sold $2.3M based on SEC Form 4 filings.
What was Soteropoulos Paula's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 27,594 DNTH shares on 2026-03-24, worth $2.2M, per SEC Form 4 filings.